ARKG Holdings of Intellia Therapeutics (NTLA) - Updated Daily
Gene TherapyGenomicsSynthetic BiologyGene Base EditingCRSPR Gene Editing
Key Statistics
Statistics
⚖️Weighting | 🧢Market Cap |
---|---|
3.97% | $2.32b |
🏋🏿♂️Weight Rank In ARKG | 🌏Country |
8 | 🇺🇸United States |
🏋️♀️Weight Rank Across All Funds | 💳ARK Estimated Cost Average |
15 | $54.51 |
🎫ARK Ownership Percent | |
2.5% |
Other ETFs That Hold NTLA
Research Notes and Commentary for NTLA
No Research Notes Found for NTLA